HALEIGH JOHNSON: Open Payments
NPI 1679336606 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,779 in 68 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,779
Food & beverage: $1,702Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $363 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $290 |
| Janssen Biotech, Inc. | 8 | $265 |
| Regeneron Healthcare Solutions, Inc. | 6 | $145 |
| Phathom Pharmaceuticals, Inc. | 2 | $118 |
| Mallinckrodt Hospital Products Inc. | 2 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $109 |
| GENZYME CORPORATION | 3 | $76 |
| VIVUS LLC | 3 | $64 |
| Ardelyx, Inc. | 3 | $59 |
Products named: XIFAXAN, TREMFYA, DUPIXENT, VOQUEZNA, TERLIVAZ, ENTYVIO, RINVOQ, LINZESS.
Industry payments across GA — which companies pay providers there.
